PURE logo

PURE PURE Bioscience, Inc.

Other OTC · Chemicals · Basic Materials

$0.07
+0.01 (+12.72%)

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company’s technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.…

Market Cap: $9.10Mwww.purebio.com

Price

No data yet.

Social Signal Score

38
5d
30
1 mentions
—
30d
30
1 mentions
—
60d
45
4 mentions
—
90d
45
4 mentions
—
news: 4

Analyst Ratings

1 analyst
Holdconsensus
Strong Buy 0Buy 0Hold 1Sell 0Strong Sell 0

Revenue

$506.0K-3.44%
$312.0K$1.52M$2.74M$3.95M
Jul 2016Apr 2026

Analyst Estimates

FY2025
$2.88
$2.88–$2.88
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jeff Kitchell
Sector
Basic Materials
Industry
Chemicals
Employees
12
Beta
0.23
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-129.86
www.purebio.com